David Gionco, Group VP & CFO at SAVIENT PHARMACEUTICALS INC (SVNT), sold 2,037 shares at $12.77 ($26K) on 2010-02-09, disclosed to the SEC on 2010-02-11.
Scheduled sale ($26k) by Group VP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| STML | SELL | 2020-03-13 | $69K | — | Filing → |
| STML | SELL | 2020-02-28 | $118K | — | Filing → |
| STML | SELL | 2020-01-03 | $49K | — | Filing → |